http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0597816-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e77f06144be4708a6ae75bd9fee56a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c13f7dda884a716a30b1bdd3cc5ae7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38f48d264ea60ba2a0302c2232ca0fa6
publicationDate 1993-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0597816-A
titleOfInvention 4-Aryl-thiazole or imidazole derivative
abstract (57) [Summary] [Structure] The present invention mainly relates to the following formula I: [In the formula, X is O or NOH, Y is S or NR 3 , Ar is a group such as phenyl and naphthyl, and R is 1 to 4 substituents independently selected from hydrogen, hydroxy, lower alkyl and the like. And R 3 represents hydrogen or lower alkyl]. And a 4-aryl-thiazole or imidazole derivative represented by [Effect] The compound of the present invention increases the sensitivity of cardiac myofibrils to calcium, has phosphodiesterase inhibitory activity and bronchodilator activity, and is useful for the treatment of heart failure and asthma patients.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007533621-A
priorityDate 1991-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228819792
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID292385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67883063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230038128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45121852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67883061
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID292385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234970594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10130961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234970591

Total number of triples: 36.